Ligand Pharmaceuticals (LGND) Insider: Stock Move Analysis
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
Explore affordable index funds for retirement and learn how low fees can boost your long-term gains. This intro covers selection basics and cost considerations.
23,808 articlesA Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
When tech stocks wobble, patient investors can uncover glorious growth stocks during downturns. This piece highlights...
Oil’s 5.7% weekly drop is fueling a rotation into jet, materials, and infrastructure plays as traders reassess fuel c...
Singapore's companies dominate the Southeast Asia 500 by revenue, capturing roughly a third of the region's total. Th...
A former chief staff mayor to NYC Mayor Eric Adams has been arrested on bribery and fraud charges, part of a widening...
The crypto market today, june is marked by a broad selloff across major tokens as inflation concerns rise and risk ap...
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Bitcoin and Ethereum options contracts are set to expire Friday, totaling around $2 billion in notional. Analysts exp...
The AI wave is accelerating, and savvy investors are looking for blue-chip names with durable AI catalysts. This guid...
The EU is gearing up for a major MiCA update in 2027 to cover non‑EU stablecoin issuers and tokenized payments. This ...
A senior executive at Invesco disclosed a stock sale as the shares jumped about 63%. This article digs into what this...
Coinbase CEO Brian Armstrong sparks a polarized debate by asking if Bitcoin's bottom is in, triggering thousands of v...